Masimo [MASI] vs Boston Scientific [BSX] Detailed Stock Comparison

Masimo

NASDAQ
Loading...

Boston Scientific

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Masimo wins in 3 metrics, Boston Scientific wins in 16 metrics, with 0 ties. Boston Scientific appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricMasimoBoston ScientificBetter
P/E Ratio (TTM)129.1657.40Boston Scientific
Price-to-Book Ratio7.456.33Boston Scientific
Debt-to-Equity Ratio61.5853.09Boston Scientific
PEG Ratio0.600.39Boston Scientific
EV/EBITDA53.6933.24Boston Scientific
Profit Margin (TTM)-21.32%13.55%Boston Scientific
Operating Margin (TTM)17.12%18.63%Boston Scientific
EBITDA Margin (TTM)17.12%18.63%Boston Scientific
Return on Equity-22.37%11.55%Boston Scientific
Return on Assets (TTM)1.84%5.39%Boston Scientific
Free Cash Flow (TTM)$145.30M$2.37BBoston Scientific
1-Year Return5.20%13.82%Boston Scientific
Price-to-Sales Ratio (TTM)3.617.72Masimo
Enterprise Value$8.26B$156.39BBoston Scientific
EV/Revenue Ratio3.838.46Masimo
Gross Profit Margin (TTM)62.90%67.65%Boston Scientific
Revenue per Share (TTM)$40$13Masimo
Earnings per Share (Diluted)$-5.15$1.67Boston Scientific
Beta (Stock Volatility)1.230.66Boston Scientific
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Masimo vs Boston Scientific Stock Performance Analysis

Loading Price Chart...

Masimo
Boston Scientific
Masimo Stock Overview | Boston Scientific Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Masimo2.46%4.51%6.03%-14.76%-14.83%-13.36%
Boston Scientific0.39%-1.96%-9.79%-7.15%-3.83%7.65%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Masimo5.20%8.76%-39.76%269.00%412.82%629.52%
Boston Scientific13.82%142.00%133.88%470.02%1,469.66%307.71%

News Based Sentiment: Masimo vs Boston Scientific

Masimo

News based Sentiment: POSITIVE

Masimo made significant strategic moves in September, including the divestiture of Sound United and an expanded partnership with Philips. These actions, coupled with positive clinical data and analyst upgrades, suggest a positive trajectory for the company, despite some mixed signals from insider activity and a recent legal settlement. The focus on core healthcare technologies positions Masimo for future growth.

View Masimo News Sentiment Analysis

Boston Scientific

News based Sentiment: POSITIVE

October brought a wave of positive signals for Boston Scientific, including increased institutional investment, raised price targets from multiple firms, and a promising long-range plan. While insider selling remains a point to watch, the overall narrative is one of strong growth potential and investor confidence.

View Boston Scientific News Sentiment Analysis

Performance & Financial Health Analysis: Masimo vs Boston Scientific

MetricMASIBSX
Market Information
Market Cap i$7.77B$142.83B
Market Cap CategoryMid capLarge cap
10 Day Avg. Volume i737,95011,631,001
90 Day Avg. Volume i655,7709,170,397
Last Close$146.05$96.22
52 Week Range$131.60 - $194.88$80.64 - $109.50
% from 52W High-25.06%-12.13%
All-Time High$305.21 (Nov 15, 2021)$109.50 (Sep 09, 2025)
% from All-Time High-52.15%-12.13%
Growth Metrics
Quarterly Revenue Growth0.08%0.23%
Quarterly Earnings Growth2.21%1.46%
Financial Health
Profit Margin (TTM) i-0.21%0.14%
Operating Margin (TTM) i0.17%0.19%
Return on Equity (TTM) i-0.22%0.12%
Debt to Equity (MRQ) i61.5853.09
Cash & Liquidity
Book Value per Share (MRQ)$19.20$15.14
Cash per Share (MRQ)$2.75$0.36
Operating Cash Flow (TTM) i$176.60M$4.28B
Levered Free Cash Flow (TTM) i$92.86M$2.94B
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend i$0.00N/A

Valuation & Enterprise Metrics Analysis: Masimo vs Boston Scientific

MetricMASIBSX
Price Ratios
P/E Ratio (TTM) i129.1657.40
Forward P/E i30.8134.35
PEG Ratio i0.600.39
Price to Sales (TTM) i3.617.72
Price to Book (MRQ) i7.456.33
Market Capitalization
Market Capitalization i$7.77B$142.83B
Enterprise Value i$8.26B$156.39B
Enterprise Value Metrics
Enterprise to Revenue i3.838.46
Enterprise to EBITDA i53.6933.24
Risk & Other Metrics
Beta i1.230.66
Book Value per Share (MRQ) i$19.20$15.14

Financial Statements Comparison: Masimo vs Boston Scientific

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)MASIBSX
Revenue/Sales i$372.00M$4.66B
Cost of Goods Sold i$138.00M$1.45B
Gross Profit i$234.00M$3.21B
Research & Development i$33.90M$443.00M
Operating Income (EBIT) i$80.70M$937.00M
EBITDA i$90.70M$1.23B
Pre-Tax Income i$68.40M$805.00M
Income Tax i$21.20M$133.00M
Net Income (Profit) i$-170.70M$672.00M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)MASIBSX
Cash & Equivalents i$130.80M$725.00M
Total Current Assets i$1.18B$7.34B
Total Current Liabilities i$546.50M$5.06B
Long-Term Debt i$657.70M$10.93B
Total Shareholders Equity i$946.40M$22.45B
Retained Earnings i$1.32B$3.35B
Property, Plant & Equipment i$183.60M$448.00M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)MASIBSX
Operating Cash Flow i$62.60M$513.00M
Capital Expenditures i$17.00M$-187.00M
Free Cash Flow i$27.00M$277.00M
Debt Repayment i$-78.80M$-1.31B
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricMASIBSX
Shares Short i3.72M19.02M
Short Ratio i6.132.76
Short % of Float i0.10%0.01%
Average Daily Volume (10 Day) i737,95011,631,001
Average Daily Volume (90 Day) i655,7709,170,397
Shares Outstanding i53.60M1.47B
Float Shares i46.46M1.48B
% Held by Insiders i0.06%0.00%
% Held by Institutions i1.10%0.94%

Dividend Analysis & Yield Comparison: Masimo vs Boston Scientific

MetricMASIBSX
Last 12-Month Dividend i$0.00N/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend i$0.00N/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends i$0.00N/A
Ex-Dividend DateN/AN/A